Anavex Life Sciences Corp... (AVXL)
NASDAQ: AVXL
· Real-Time Price · USD
9.91
-0.20 (-1.98%)
At close: Aug 15, 2025, 3:59 PM
10.26
3.48%
After-hours: Aug 15, 2025, 06:30 PM EDT
Anavex Life Sciences Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -14.46M | -12.51M | -13.59M | -14.34M | -14.73M | -12.62M | -11.38M | -12.65M | -13.53M | -14.19M | -15.36M | -15.28M | -12.46M | -11.52M | -11.72M | -12.25M | -11.36M | -8.94M | -9.4M |
Interest Income | 1.07M | 1.21M | 1.39M | 1.76M | 1.8M | 1.76M | 2.01M | 1.96M | 1.83M | 1.47M | 1.27M | 704.58K | 229.92K | 7.58K | n/a | 7.15K | 11.45K | 9.22K | n/a |
Pretax Income | -13.37M | -11.29M | -12.52M | -11.74M | -12.28M | -10.55M | -9.21M | -10.21M | -11.24M | -13.06M | -12.99M | -14.08M | -12.28M | -10.41M | -10.85M | -11.58M | -10.14M | -8.13M | -7.8M |
Net Income | n/a | -11.2M | -12.11M | -11.62M | -12.21M | -10.55M | -8.62M | -10.15M | -11.28M | -13.11M | -12.97M | -14.29M | -12.37M | -10.44M | -10.88M | -11.72M | -10.18M | -8.15M | -7.86M |
Selling & General & Admin | 4.5M | 2.62M | 3.15M | 2.78M | 2.86M | 2.79M | 2.61M | 2.59M | 3.25M | 2.88M | 3.32M | 3.9M | 3.19M | 2.92M | 3.07M | 2.88M | 2.43M | 2.23M | 1.47M |
Research & Development | 9.96M | 9.89M | 10.45M | 11.55M | 11.87M | 9.73M | 8.68M | 10.06M | 10.28M | 10.56M | 12.07M | 11.38M | 9.27M | 8.61M | 8.66M | 9.37M | 8.96M | 6.72M | 7.93M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 85K | -1K | n/a | 750K | -25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 14.46M | 12.51M | 13.59M | 14.34M | 14.73M | 12.52M | 11.38M | 12.65M | 13.53M | 14.19M | 15.36M | 15.28M | 12.46M | 11.52M | 11.72M | 12.25M | 11.36M | 8.94M | 9.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 964K | n/a | n/a | n/a | n/a | 4.91K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.46M | 12.51M | 13.59M | 14.34M | 14.73M | 12.62M | 11.29M | 12.65M | 13.53M | 14.19M | 15.36M | 15.28M | 12.46M | 11.52M | 11.72M | 12.25M | 11.36M | 8.94M | 9.4M |
Income Tax Expense | -127K | -96K | -412K | -124K | -67K | 105K | n/a | -63.95K | 41K | 50K | -20.05K | 210.29K | 88.42K | 29.8K | 29.98K | 142.3K | 39K | 26.99K | 59.28K |
Shares Outstanding (Basic) | 85.38M | 85.07M | 84.81M | 84M | 84.53M | 82.46M | 82.08M | 79.79M | 80.88M | 78.3M | 77.98M | 76.91M | 77.44M | 76.25M | 76M | 75.78M | 70.59M | 68.59M | 64.3M |
Shares Outstanding (Diluted) | 85.38M | 85.07M | 84.81M | 84M | 84.53M | 82.46M | 82.08M | 79.79M | 80.88M | 78.3M | 77.98M | 76.91M | 77.44M | 76.25M | 76M | 76M | 70.59M | 68.59M | 64.3M |
EPS (Basic) | -0.16 | -0.13 | -0.14 | -0.14 | -0.14 | -0.13 | -0.1 | -0.13 | -0.14 | -0.17 | -0.17 | -0.19 | -0.16 | -0.14 | -0.14 | -0.15 | -0.14 | -0.12 | -0.12 |
EPS (Diluted) | -0.16 | -0.13 | -0.14 | -0.14 | -0.14 | -0.13 | -0.1 | -0.13 | -0.14 | -0.17 | -0.17 | -0.19 | -0.16 | -0.14 | -0.14 | -0.15 | -0.14 | -0.12 | -0.12 |
EBITDA | -13.37M | -11.29M | -12.52M | -34.02M | -12.27M | -11.02M | -9.21M | -10.88M | -11.24M | -12.09M | -15.36M | -15.28M | -12.28M | -11.52M | -11.72M | -12.25M | -11.36M | -8.94M | -9.4M |
EBIT | -13.37M | -11.29M | -12.52M | -12.44M | -14.2M | -11.02M | -9.21M | -10.88M | -11.24M | -12.09M | -15.36M | -15.28M | -12.28M | -11.52M | -11.72M | -12.25M | -10.04M | -8.94M | -9.4M |
Depreciation & Amortization | n/a | 12.42M | 1.06M | -22.75M | 14.2M | 12.05M | n/a | n/a | 12.97M | 13.44M | 14.65M | 14.29M | 11.78M | 10.68M | 10.91M | 11.3M | 10.04M | 7.99M | 8.13M |